Grace Gallagher

10PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 15, 2026
Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments.

|Mar 11, 2026
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer.

Jenna Bhimani, Kelli O'Connell, Victoria S Blinder

|Feb 24, 2026
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer.

Maria J Monroy-Iglesias, Kelli O'Connell, Jenna Bhimani

|Dec 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer.

Yashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell

|Nov 05, 2025
Provider billing margin and cancer treatment selection: population based cohort study.

Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza

|Feb 14, 2025
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study.

Peng Wang, Kelli O'Connell, Jenna Bhimani

Pageof 2

Frequent Collaborators

6 joint publications

Isaac J Ergas

6 joint publications

Candyce H Kroenke

6 joint publications

Elizabeth D Kantor

6 joint publications

Sonia Persaud